Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Emedastine
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/28/2020
Omeprazole
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/28/2020
Triclabendazole
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/28/2020
FRIL
Potential treatment - pre-clinical evidence Natural product Antiviral Jul/24/2020
SL-11128
Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020
N-tert-Butylisoquine
Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020
R-82913
Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020
8-(3-Chlorostyryl)caffeine
Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020
AMG-2674
Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020
KW-8232
Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020
SB-616234-A
Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020
Elopiprazole
Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020
SDZ-62-434
Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020
YH-1238
Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020
DS-6930
Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020
VBY-825
Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020
Z LVG CHN2
Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020
ONO 5334
Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020
MDL-28170
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/24/2020
MLN-3897
Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020